Name:  ___                    Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: PLASTIC
 
Allergies: 
Tetracycline
 
Attending: ___.
 
Chief Complaint:
Right breast cancer
 
Major Surgical or Invasive Procedure:
1) Right partial mastectomy plus right axillary sentinel node 
biopsy.
2) Bilateral Reduction Mammoplasty

 
History of Present Illness:
___ perimenopausal ___ female 
with history of AML in ___. She recently palpated a right 
breast mass that is 1.5 to 1.8 cm by breast imaging and s/p 
core-needle biopsy revealing grade 3 triple negative breast 
cancer.

 
Past Medical History:
-AML (___) in remission, followed at ___ by Dr. ___ thrombocythemia (since ___ - followed by Dr.
___ treated with anagrelide for ___ years.  Also tried
Hydrea in ___ but stopped due to hair thinning.  Check to
negative in ___ and ___.  Calreticulan mutation 
positive.
.
PAST SURGICAL HISTORY:
- cesarian section (only for ___ child)

 
Social History:
___
Family History:
___ and ___ ancestry. No family history of 
breast, ovarian or gastric cancer.  Paternal aunt had lung 
cancer (smoker), paternal aunt had brain cancer.

 
Physical Exam:
Physical exam as documented in plastic surgery POC note 
___:
AVSS
 NAD
 Regular rate, warm and perfused
 Clear, breathing comfortably
 Abdomen soft, nontender
 Extremities WWP, minimal edema
 Surgical Site: breasts appropriately tender, soft, no 
ecchymosis, drainage is minimal and serosanguinous, no evidence 
of hematoma. Incisions c/d/I, pt in surgical bra with ABDs in 
place. 

 
Brief Hospital Course:
The patient was admitted to the plastic surgery service on 
___ and had a oncoplastic breast reduction following right 
lumpectomy.  The patient tolerated the procedure well. 
 .
 Neuro: Post-operatively, the patient received IV pain 
medication with good effect and adequate pain control. When 
tolerating oral intake, the patient was transitioned to oral 
pain medications. 
 .
 CV: The patient was stable from a cardiovascular standpoint; 
vital signs were routinely monitored.
 .
 Pulmonary: The patient was stable from a pulmonary standpoint; 
vital signs were routinely monitored.
 .
 GI/GU: Post-operatively, the patient was given IV fluids until 
tolerating oral intake.  Her diet was advanced when appropriate, 
which was tolerated well. She was also started on a bowel 
regimen to encourage bowel movement. Intake and output were 
closely monitored. 
 .
 ID: Post-operatively, the patient was started on IV cefazolin, 
then switched to PO cefadroxil for discharge home. The patient's 
temperature was closely watched for signs of infection. 
 .
 Prophylaxis: The patient received subcutaneous heparin during 
this stay, and was encouraged to get up and ambulate as early as 
possible. 
 .
 At the time of discharge on POD#1, the patient was doing well, 
afebrile with stable vital signs, tolerating a regular diet, 
ambulating, voiding without assistance, and pain was well 
controlled. Bilateral breasts were soft and symmetrical, 
incisions intact, no evidence of hematoma, surgibra in place.

 
Medications on Admission:
anagrelide 1 mg oral Q24H  
Aspirin 81 mg PO DAILY  

 
Discharge Medications:
1.  Acetaminophen 1000 mg PO Q8H  
2.  cefaDROXil 500 mg oral BID 
RX *cefadroxil 500 mg 1 capsule(s) by mouth twice a day Disp 
#*10 Capsule Refills:*0 
3.  Docusate Sodium 100 mg PO BID 
RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day 
Disp #*30 Capsule Refills:*0 
4.  OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - 
Moderate 
RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours 
Disp #*40 Tablet Refills:*0 
5.  anagrelide 1 mg oral Q24H  
6.  Aspirin 81 mg PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Right breast cancer

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted for an oncoplastic breast reduction following 
right lumpectomy. Please follow these discharge instructions.
 .
 Personal Care: 
 1. Leave any surgical dressings in place for 48 hours after 
surgery and then they may be removed and the incisions left open 
to air. 
 2. You should keep your surgibra in place for 2 weeks after 
surgery. You may remove for showering/laundering.  Do not take a 
bath or swim for 2 weeks after surgery. 
 . 
 Diet/Activity: 
 1. You may resume your regular diet. 
 2. DO NOT lift anything heavier than 5 pounds or engage in 
strenuous activity for two weeks after surgery. 
 . 
 Medications: 
 1. Resume your regular medications unless instructed otherwise 
and take any new meds as ordered. 
 2. You may take your prescribed pain medication for moderate to 
severe pain. You may switch to Tylenol or Extra Strength Tylenol 
for mild pain as directed on the packaging.  
 3. Take Colace, 100 mg by mouth 2 times per day, while taking 
the prescription pain medication. You may use a different 
over-the-counter stool softener if you wish. 
 4. Do not drive or operate heavy machinery while taking any 
narcotic pain medication. You may have constipation when taking 
narcotic pain medications (oxycodone, percocet, vicodin, 
hydrocodone, dilaudid, etc.); you should continue drinking 
fluids, you may take stool softeners, and should eat foods that 
are high in fiber. 
 . 
 Call the office IMMEDIATELY if you have any of the following: 
 1. Signs of infection: fever with chills, increased redness, 
swelling, warmth or tenderness at the surgical site, or unusual 
drainage from the incision(s). 
 2. A large amount of bleeding from the incision(s) or drain(s). 

 3. Fever greater than 101.5 oF 
 4. Severe pain NOT relieved by your medication. 
 . 
 Return to the ER if: 
 * If you are vomiting and cannot keep in fluids or your 
medications. 
 * If you have shaking chills, fever greater than 101.5 (F) 
degrees or 38 (C) degrees, increased redness, swelling or 
discharge from incision, chest pain, shortness of breath, or 
anything else that is troubling you. 
 * Any serious change in your symptoms, or any new symptoms that 
concern you.
 
Followup Instructions:
___